| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
2,970,000 |
| Market
Cap: |
1.11(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3751 - $0.3751 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile OncoSec Medical is a immuno-oncology company focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics to stimulate and to guide anti-tumor immune responses for the treatment of cancers. Co.'s main technology platform ImmunoPulse® is a drug-device therapeutic modality platform comprised of proprietary intratumoral electroporation (EP) delivery devices (the OncoSec Medical System (OMS) EP Device) and a proprietary DNA plasmid. The OMS EP Device is designed to deliver plasmid DNA-encoded drugs into a solid tumor and promote an immunological response against cancer. Co.'s main product candidate is a DNA-encoded interleukin-12 called tavokinogene telseplasmid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
607 |
| Total Sell Value |
$0 |
$0 |
$0 |
$362 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dhillon Punit |
President and CEO |
• – – |
2016-07-31 |
4 |
B |
$1.44 |
$4,320 |
I/I |
3,000 |
765,501 |
1.91 |
- |
|
| Mohan-Peterson Sheela |
Chief Legal Officer |
• – – |
2015-10-16 |
4 |
B |
$4.24 |
$2,205 |
D/D |
520 |
520 |
2.66 |
- |
|
| Dhillon Avtar S |
Director |
– • – |
2015-10-16 |
4 |
B |
$4.36 |
$43,590 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Dhillon Punit |
President and CEO |
• • – |
2015-10-16 |
4 |
B |
$4.20 |
$42,485 |
D/D |
10,000 |
100 |
2.81 |
- |
|
| Slansky Richard B |
Chief Financial OfficerOfficer |
• – – |
2015-07-06 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2015-07-06 |
4 |
B |
$6.12 |
$918,000 |
D/D |
150,000 |
150,000 |
2.74 |
- |
|
| Slansky Richard B |
Chief Financial OfficerOfficer |
• – – |
2015-06-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Dhillon Punit |
President and CEO |
• • – |
2015-06-10 |
4 |
B |
$6.73 |
$16,846 |
D/D |
2,500 |
2,500 |
2.81 |
- |
|
| Maida Anthony E III |
Director |
– • – |
2014-03-20 |
4 |
B |
$0.81 |
$18,565 |
I/I |
22,800 |
22,800 |
2.1 |
- |
|
| Dhillon Punit |
President and CEO |
• – – |
2014-03-19 |
4 |
B |
$0.80 |
$40,000 |
D/D |
50,000 |
4,444,000 |
2.74 |
- |
|
| Vallejo Veronica |
Principal Financial OfficerOff |
• – – |
2011-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200,000 |
|
- |
|
| Cross Michael |
Chief Operating OfficerOfficer |
• – – |
2011-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,214,000 |
|
- |
|
| Dhillon Punit |
President and CEOOfficer |
• – – |
2011-03-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
752,000 |
|
- |
|
| Dhillon Punit |
President and CEOOfficer |
• – – |
2011-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,642,000 |
|
- |
|
| Dhillon Avtar S |
Director |
– • • |
2011-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,910,480 |
|
- |
|
| Dhillon Punit |
President and CEO |
• – – |
2011-03-01 |
4 |
B |
$0.00 |
$226 |
I/I |
752,000 |
4,394,000 |
1.91 |
- |
|
| Dhillon Punit |
President and CEO |
• – – |
2011-03-01 |
4 |
B |
$0.00 |
$1,093 |
D/D |
3,642,000 |
4,394,000 |
2.66 |
- |
|
| Cross Michael |
Chief Operating Officer |
• – – |
2011-03-01 |
4 |
B |
$0.00 |
$364 |
D/D |
1,214,000 |
1,214,000 |
2.66 |
- |
|
| Vallejo Veronica |
Principal Financial Officer |
• – – |
2011-03-01 |
4 |
B |
$0.00 |
$60 |
D/D |
200,000 |
200,000 |
2.66 |
- |
|
| Demesa James M |
Director |
– • – |
2011-03-01 |
4 |
B |
$0.00 |
$75 |
D/D |
250,000 |
250,000 |
2.31 |
- |
|
| Dhillon Avtar S |
Director |
– • • |
2011-03-01 |
4 |
B |
$0.00 |
$2,973 |
D/D |
9,910,480 |
9,910,480 |
3.84 |
- |
|
121 Records found
|
|
Page 5 of 5 |
|
|
